GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Magle Chemoswed Holding AB (OSTO:MAGLE) » Definitions » Return-on-Tangible-Equity

Magle Chemoswed Holding AB (OSTO:MAGLE) Return-on-Tangible-Equity : 15.65% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Magle Chemoswed Holding AB Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Magle Chemoswed Holding AB's annualized net income for the quarter that ended in Mar. 2024 was kr11.8 Mil. Magle Chemoswed Holding AB's average shareholder tangible equity for the quarter that ended in Mar. 2024 was kr75.2 Mil. Therefore, Magle Chemoswed Holding AB's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 was 15.65%.

The historical rank and industry rank for Magle Chemoswed Holding AB's Return-on-Tangible-Equity or its related term are showing as below:

OSTO:MAGLE' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -8.47   Med: 3.95   Max: 17.51
Current: 17.12

During the past 6 years, Magle Chemoswed Holding AB's highest Return-on-Tangible-Equity was 17.51%. The lowest was -8.47%. And the median was 3.95%.

OSTO:MAGLE's Return-on-Tangible-Equity is ranked better than
91.72% of 1305 companies
in the Biotechnology industry
Industry Median: -47.16 vs OSTO:MAGLE: 17.12

Magle Chemoswed Holding AB Return-on-Tangible-Equity Historical Data

The historical data trend for Magle Chemoswed Holding AB's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magle Chemoswed Holding AB Return-on-Tangible-Equity Chart

Magle Chemoswed Holding AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial 1.20 2.11 5.78 14.58 17.51

Magle Chemoswed Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.96 26.87 3.15 22.94 15.65

Competitive Comparison of Magle Chemoswed Holding AB's Return-on-Tangible-Equity

For the Biotechnology subindustry, Magle Chemoswed Holding AB's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Magle Chemoswed Holding AB's Return-on-Tangible-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Magle Chemoswed Holding AB's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Magle Chemoswed Holding AB's Return-on-Tangible-Equity falls into.



Magle Chemoswed Holding AB Return-on-Tangible-Equity Calculation

Magle Chemoswed Holding AB's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=12.169/( (64.26+74.744 )/ 2 )
=12.169/69.502
=17.51 %

Magle Chemoswed Holding AB's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=11.776/( (74.744+75.734)/ 2 )
=11.776/75.239
=15.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Magle Chemoswed Holding AB  (OSTO:MAGLE) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Magle Chemoswed Holding AB Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Magle Chemoswed Holding AB's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Magle Chemoswed Holding AB (OSTO:MAGLE) Business Description

Traded in Other Exchanges
N/A
Address
Agneslundsvagen 27, Malmo, SWE, 21215
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.

Magle Chemoswed Holding AB (OSTO:MAGLE) Headlines

No Headlines